{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20260227",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "85219",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/219164Orig1s000ltr.pdf",
              "date": "20260303",
              "type": "Letter"
            },
            {
              "id": "85266",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/219164Orig1s000lbl.pdf",
              "date": "20260304",
              "type": "Label"
            },
            {
              "id": "85921",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2026/219164Orig1s000TOC.html",
              "date": "20260707",
              "type": "Review"
            }
          ]
        }
      ],
      "application_number": "NDA219164",
      "sponsor_name": "ASCENDIS",
      "openfda": {
        "application_number": [
          "NDA219164"
        ],
        "brand_name": [
          "YUVIWEL"
        ],
        "generic_name": [
          "NAVEPEGRITIDE"
        ],
        "manufacturer_name": [
          "Ascendis Pharma Endocrinology, Inc."
        ],
        "product_ndc": [
          "73362-201",
          "73362-202",
          "73362-203"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "rxcui": [
          "2739524",
          "2739529",
          "2739531",
          "2739533",
          "2739535",
          "2739537"
        ],
        "spl_id": [
          "7bc0f18a-5736-4451-8790-f3780b742ab3"
        ],
        "spl_set_id": [
          "e01c1197-338f-414c-b804-808e129ebc8c"
        ],
        "package_ndc": [
          "73362-201-02",
          "73362-201-01",
          "73362-205-01",
          "73362-801-01",
          "73362-202-02",
          "73362-202-01",
          "73362-206-01",
          "73362-203-02",
          "73362-203-01",
          "73362-207-01"
        ]
      },
      "products": [
        {
          "product_number": "002",
          "reference_drug": "Yes",
          "brand_name": "YUVIWEL",
          "active_ingredients": [
            {
              "name": "NAVEPEGRITIDE",
              "strength": "2.8MG/VIAL"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "POWDER",
          "route": "SUBCUTANEOUS",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "003",
          "reference_drug": "Yes",
          "brand_name": "YUVIWEL",
          "active_ingredients": [
            {
              "name": "NAVEPEGRITIDE",
              "strength": "5.5MG/VIAL"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "POWDER",
          "route": "SUBCUTANEOUS",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "YUVIWEL",
          "active_ingredients": [
            {
              "name": "NAVEPEGRITIDE",
              "strength": "1.3MG/VIAL"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "POWDER",
          "route": "SUBCUTANEOUS",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}